Clinical Trials Sponsored by AGIR a Dom

Total 135 results

AGIR à Dom
AIR LIQUIDE MEDICAL SYSTEMS

Not yet recruiting

Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome (NINADOM)

Apnea, Obstructive

France
AGIR à Dom

Not yet recruiting

Trained Patient Involvement to Promote the Resumption of CPAP in Patients Who Have Discontinued Its Use

Obstructive Sleep Apnea Syndrome
AGIR à Dom

Terminated

Impact of Sleep Apnea on Diabetic Foot Wound. (SAS-FOOT)

Diabetic Foot | Sleep Apnea

France
AGIR à Dom

Completed

Impact of Non-intentional Leaks on Noninvasive Ventilation (NIV-Leaks)

Respiratory Physiological Phenomena | Intermittent Positive-pressure Ventilation

France
AGIR à Dom

Completed

Prevalence of Obesity Hypoventilation Syndrome (BIO-OHS)

Obesity Hypoventilation Syndrome

France
AGIR à Dom

Completed

Sleep Apnea in Frail Elderly (SAFE)

Sleep Apnea | Ageing

France
AGIR à Dom

Not yet recruiting

Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation (VNI_SLA)

ALS | Charcot Disease

France
AGIR à Dom

Unknown

Effects of Expiratory Pressure on Arterial Oxygenation During Hypoxia (hypex)

Hypoxia

France
AGIR à Dom

Recruiting

Impact of Tele-visit on Patients Continous Positive Airway Pressure (CPAP) Follow-up by Home Care Provider (i-tech PPC)

Obstructive Sleep Apnea

France
AGIR à Dom

Withdrawn

Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma (MELA-SAS)

Obstructive Sleep Apnea Syndrome | Melanoma With a Breslow's Thickness ≥ 1mm

France
AGIR à Dom

Completed

Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure (AgirSASadom)

Obstructive Sleep Apnea Syndrome

France
Icadom
AGIR à Dom

Completed

Lifestyle Intervention in Type 2 Diabetes (WeightPump)

Type 2 Diabetes Treated With Insulin

France
Icadom
AGIR à Dom

Completed

Eating Disorders in Type 1 Insulin-dependent Diabetes Patients (Diaboulimia)

Type 1 Diabetes | Eating Disorders

France
AGIR à Dom
ResMed

Completed

Target Volume in Noninvasive Positive Pressure Ventilation (CIBLE)

Obesity Hypoventilation Syndrome

France
ResMed
DOM AIR

Withdrawn

Evaluation of Prophylactic Heated Humidification on Obstructive Sleep Apnea (OSA) Patient Short Term Compliance to CPAP Therapy (Humidifier)

Osa Syndrome

France
University Hospital, Grenoble
AGIR à Dom; Commissariat A L'energie Atomique; AIRFAN

Completed

Sleep Apnea : Diagnosis and Monitoring (ApneaBand)

Obstructive Sleep Apnea

France
University Hospital, Grenoble
AGIR à Dom

Completed

Healthcare Renunciation in Respiratory Chronic Disease and Treatment Compliance (OBSERVE) (OBSERVE)

Respiratory Failure | Obstructive Sleep Apnea

France
AGIR à Dom
University Hospital, Grenoble

Unknown

Phase II Study of Neuromuscular Electrical Multisite System on Cardiovascular Effects in Severe Obese Patients (StimobII)

Obesity | Training | Electrical Stimulation | Arterial Stiffness | Cardiovascular

France
University Hospital, Grenoble
AGIR à Dom

Unknown

Evaluation of Sleep Apnea and Cardiac Rhythm Abnormalities After Surgery Under General Anesthesia (Etude3A)

Obstructive Sleep Apnea | Arrhythmia
University Hospital, Grenoble
AGIR à Dom

Completed

Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients (TELFIT)

Type 1 Diabetes Mellitus

France
University Hospital, Grenoble
AGIR à Dom

Not yet recruiting

Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study (APAMAdom)

Anorexia Nervosa

France
University Hospital, Grenoble
AGIR à Dom

Recruiting

Early Supported Discharge and Enhanced Homecare After Emergency Department Admission for Acute Exacerbation of COPD (EXADOM)

COPD

France
AGIR à Dom
University Hospital, Grenoble

Unknown

OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training (OBEX1)

Obesity | Sleep Apnea

Canada, France
University Hospital, Grenoble
AGIR à Dom

Unknown

Effects of Hypoxia and Inflammation on Citrulline Synthesis by Ornithine Transcarbamylase in Human Enterocytes (HYPOCITRE)

Inflammation | Hypoxia | Chronic Obstructive Pulmonary Disease

France
AGIR à Dom
University Hospital, Grenoble

Unknown

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension (RAP)

Sleep Apnea | Hypertension, Resistant to Conventional Therapy

France, Canada, Switzerland
AGIR à Dom
University Hospital, Grenoble

Completed

Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease (FreeO2-rehab)

COPD | Hypercapnia | Oxygen Therapy

France
University Hospital, Grenoble
AGIR à Dom

Completed

Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants (BRONDUSAL)

Bronchiolitis

France
University Hospital, Grenoble
AGIR à Dom

Completed

Exercise Intolerance in Obstructive Sleep Apnea Syndrome Patients (EXAOS)

Obstructive Sleep Apnea

France
University Hospital, Grenoble
AGIR à Dom; Dreem

Recruiting

Sleep Quality Evolution: Dreem Under CPAP

Obstructive Sleep Apnea | Sleep Apnea

France
University Hospital, Grenoble
ResMed; AGIR à Dom

Terminated

Innovation in NOn Invasive Ventilation in COPD Patients Treated by Long Term Oxygen Therapy (INOV-LTOT)

Chronic Obstructive Pulmonary Disease

France
University Hospital, Grenoble
AGIR à Dom; Aqsitania SAS

Unknown

Validation of the Respiratory Function of Pulmonary Transplants to Anticipate Unplanned Hospitalizations (TRANSADOM)

Lung Transplant; Complications

France
Diabeloop
AGIR à Dom; Icadom; CHU Grenoble Alpes

Completed

Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1 (DT2_1)

Type 2 Diabetes Treated With Insulin

France
University Hospital, Grenoble
AGIR à Dom; Philips Healthcare

Terminated

Impact of a Telemonitoring Program on the Rate of Hospitalizations for Worsening of Cardio-respiratory Symptoms in COPD Patients Treated at Home by Long-term Non-invasive Ventilation (NIV) (EXA-VNI2)

Chronic Obstructive Pulmonary Disease

France
University Hospital, Grenoble
AGIR à Dom; Université Joseph Fourier

Completed

Personal Lifestyle Assistant for Better Health Through Nutrition (C2H)

Healthy

France
AGIR à Dom
Laboratoire TIMC-IMAG; DrinkHRW, British Columbia, Canada

Active, not recruiting

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care (HYDRO COVID)

Covid19 | SARS-CoV-2 | AMBULATORY CARE

France, Morocco, Serbia
Fundação Educacional Serra dos Órgãos
Melora do Brasil Produtos Dermatológicos S/A

Completed

Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness

Motion Sickness

Brazil
Diabeloop
University Hospital, Grenoble; AGIR à Dom; Icadom; Centre Hospitalier Annecy Genevois and other collaborators

Completed

Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2) (Close2target)

Diabetes Mellitus Type 2 - Insulin-Treated

France
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Recruiting

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Advanced Solid Tumor

Netherlands
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer (COLSTAR)

Metastatic Colorectal Cancer

Denmark, Japan, Belgium, Finland, Hungary, United States
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

Acute Myeloid Leukaemia

France, United States, Australia
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)

United States, Australia, France, Spain
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Austria, France, Hungary, United Kingdom, Italy, Germany, Spain
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Active, not recruiting

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

Solid Tumor

United States, Canada
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Active, not recruiting

A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19

Advanced Lymphoid Leukemia

United States, United Kingdom, Japan, France, Spain
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.

Autism Spectrum Disorder (ASD)

Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Withdrawn

S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC

Esophageal Squamous Cell Carcinoma
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder

Autism Spectrum Disorder (ASD)

Spain, Hungary, Poland, Brazil, France, Italy, Portugal, United Kingdom, Germany, Netherlands
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia (PALL)

Refractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic Leukemia

United States, France, Spain, United Kingdom
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1)

Metastatic Colorectal Cancer

United Kingdom, Spain, Germany, Poland, Australia, Belgium, Brazil, Denmark, France, Italy, Netherlands, Russian Federation

Clinical Trials Sponsored by AGIR a Dom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations